Well, that's what happens when your mindset is Trump did it, therefore it's bad and has to be stopped.
cancel2 2022 (01-22-2021), dukkha (01-22-2021), PostmodernProphet (01-22-2021), RB 60 (01-23-2021)
Funny thing about that article. It doesn't say Biden made insulin expensive again. It says he put on hold a rule that was finalized in late December. The thing about rules is that they don't take effect immediately. The particular rule referred to wasn't scheduled to take effect until Jan 22. Then the rule only affects some clinics and patients of those clinics making less than $44,000.
So, your title is one big lie. The price of insulin today is the same that it was on Dec 21. Biden didn't change that price one cent. Even if the rule had gone into effect, it wouldn't have changed the cost of insulin for 90% of people getting insulin.
"We are all born ignorant, but one must work hard to remain stupid."
"Any fool can criticize, condemn and complain - and most fools do."
no worries (01-23-2021), Nordberg (01-22-2021), ThatOwlWoman (01-22-2021)
Bump
1. The policy was not yet in effect.
2. The policy only applied to community health centers that got Federal funds.
3. The savings were only going to be passed on to people earning less then $44,000 who had no insurance. (No one had received these savings because the policy never went into effect.)
4. It only passed on discounts which means if there were no discounts then no one saved any money.
Bottom line - Your title is still a lie.
"We are all born ignorant, but one must work hard to remain stupid."
"Any fool can criticize, condemn and complain - and most fools do."
no worries (01-23-2021), ThatOwlWoman (01-22-2021)
The Big Pharma oligarchs want what they paid for, and they wanted their obscene profits back.
https://www.newsweek.com/big-pharma-...ricing-1534809
https://www.pharmaceutical-technolog...arma-industry/
Trump released an Executive Order (EO) on September 13 2020 in an effort to lower drug prices under a "most favored nations" pricing scheme.
Under the plan, Medicare would refuse to pay more for drugs than other developed nations, which generally pay less than the U.S. The measure covered Medicare parts B and D.
The pharmaceuticals and health products industry donated more than $5.9 million to the usurper, according to OpenSecrets.org, a site run by the Center for Responsive Politics, which tracks political donations.
https://www.newsweek.com/big-pharma-joe-biden-fix-drug-pricing-1534809
maybe if trump had let his HHS team coordinate more closely with Biden's soon after biden kicked his ass in a fair election, this process might not take as long, but it is customary for new presidents and their new HHS team and other experts they appoint, to pause new programs set by outgoing presidents that have not taken effect yet so they can review them for themselves- as is the case here....
besides, I thought repubs were against Big Nanny Government to tell private companies how much they should charge to whom and when? Don't repubs want less regulations on private industry? Don't they claim they want the private sector and the free marketplace to rule, not Big Brother to come in and decide winners and losers? hypocrite, much?
From insulin to life-saving medical devices to last-ditch efforts to protect premature infants (including those from “live birth” abortions), multiple rules posted by the Health and Human Services Department in the final days of Donald Trump’s presidency are subject to a 60-day pause.
The halt on Trump-era rulemaking includes two controversial rules designed to curb high drug prices—one that changes the way pharmacy liaisons and drugmakers can pay each other and another that ties Medicare rates for expensive drugs to the prices paid in other countries.
A Wednesday memo circulated by White House Chief of Staff Ronald Klain said all rules, guidances, or other agency actions that didn’t take effect prior to noon that day—the official handover time from Trump to President Joe Biden—will be subject to review by the new administration before they can take effect. If the previous administration’s actions raise questions of “fact, law, or policy,” the designated officials now leading the agencies can further delay effective dates and consult with the Office of Management and Budget about other actions. The agencies can also open comment periods on those actions.
If there are no such questions, no further action is needed. The rule, proposal, or guidance can be considered active and effective, the memo said.
A regulatory pause is a common tradition among incoming presidents to ensure that the unfinished policies from the prior administration align with the new one. In many cases, there are no substantial disagreements among the two administrations and the policies can continue on their normal path. But the pause gives incoming officials a chance to weed out the actions that go against the current president’s stance.
The HHS issued a slew of rules and other announcements in the weeks leading up to Biden’s inauguration, including a substantial change to a Medicare payment model for expensive prescription drugs as late as Jan. 19.
https://news.bloomberglaw.com/pharma...rticle-related
no worries (01-23-2021)
These are non-profit community health centers, so they already in effect pass on all discounts to their patients. The difference is they can no longer move around which patients they pass it on to, and they will have to fill out more paperwork. So all the rule does is increase average prices (the more paperwork), and increase prices on those that can pay the least.
Bookmarks